Stable coronary heart disease: diagnosis and treatment
- Authors: Glezer M.1
-
Affiliations:
- I.M. Sechenov First Moscow State Medical University (Sechenov University)
- Issue: Vol 29, No 12 (2018)
- Pages: 37-41
- Section: Articles
- URL: https://journals.eco-vector.com/0236-3054/article/view/117424
- DOI: https://doi.org/10.29296/25877305-2018-12-09
- ID: 117424
Cite item
Open Access
Access granted
Abstract
The first clinical manifestation of coronary heart disease (CHD) is often angina pectoris in women and myocardial infarction in men. The paper gives an algorithm for the diagnosis and treatment in stable CHD.
Keywords
Full Text
About the authors
M. Glezer
I.M. Sechenov First Moscow State Medical University (Sechenov University)
Email: 287ast@mail.ru
Professor, MD
References
- Рекомендации по лечению стабильной ишемической болезни сердца Европейского общества кардиологов, 2013. Адаптированный перевод // Рос. кардиол. журн. - 2014; 7: 7-79.
- Sekiya M., Sato M., Funada J. et al. Effects of the long-term administration of nicorandil on vascular endothelial function and the progression of arteriosclerosis // J. Cardiovasc. Pharmacol. - 2005; 46 (1): 63-7.
- Zhu W., Shan Y., Guo J. et al. Double-blind, multicenter active-controlled, randomized clinical trial to assess the safety and efficacy of orally administered nicorandil in patients with stable angina pectoris in China // Circ. J. - 2007; 71 (6): 826-33.
- The IONA Study Group. Effect of nicorandil on coronary events in patients with stable angina: the Impact Of Nicorandil in Angina (IONA) randomised trial // Lancet. - 2002; 359: 1269-75.
- Horinaka S., Yabe A., Yagi H. et al. Effects of nicorandil on cardiovascular events in patients with coronary artery disease in the Japanese Coronary Artery Disease (JCAD) study // Circ. J. - 2010; 74 (3): 503-9.
- Sakata Y., Nakatani D., Shimizu M. et al. Oral treatment with nicorandil at discharge is associated with reduced mortality after acute myocardial infarction // J. Cardiol. - 2012; 59 (1): 14-21.
- Булахова Е.Ю., Кореннова О.Ю., Кондрашева М.Н. и др. Клинические преимущества терапии никорандилом в сравнении с изосорбид-5-мононитратом у больных ИБС // Сердце. - 2013; 2 (70): 83-7.
Supplementary files
